Autifony Therapeutics Investors

16 investors on Angel Roster list Autifony Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Autifony Therapeutics can appear together.

Investors listed
16
With verified email
31%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 16 Autifony Therapeutics investors

The most complete profiles first. Showing 16 of 16.

  • Eugene HillVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Verified email available

  • Jack KenneyVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Paul LaVioletteVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more

    Verified email available

  • Tom FlynnVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Elizabeth Blake SchwertVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Mike RossVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Christian B. Jung, PhD

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Gen2 Neuroscience, Nordic, Alector, Mitoconix Bio and 13 more

    Contact details available

  • Gregory Madden

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more

    Contact details available

  • Houman Ashrafian

    Venture Capital, Investor · United Kingdom

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Contact details available

  • Jonathan Behr

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Gen2 Neuroscience, Nordic, Alector, Mitoconix Bio and 13 more

    Contact details available

  • Laurence Barker

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Gen2 Neuroscience, Nordic, Alector, Mitoconix Bio and 13 more

    Contact details available

  • Michael Balmuth

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Contact details available

  • Angus Grant

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Gen2 Neuroscience, Nordic, Alector, Mitoconix Bio and 13 more

    Contact details available

  • Brent Faduski

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Carl Culicchia

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Maina Bhaman

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedBiotechnologyClean TechnologyElectronic Health Records (EHR)Health and Hospital Services

    Portfolio: Autifony Therapeutics, Psioxus Therapeutics, Kuur Therapeutics, Sitryx Therapeutics and 3 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Autifony Therapeutics investors are on Angel Roster?

Angel Roster lists 16 Autifony Therapeutics investors. 5 of them (31%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (16) and Private Equity Firms (7). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Autifony Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (11).

Where are Autifony Therapeutics investors based?

Most are based in the United States (12) and the United Kingdom (4).

Which companies have Autifony Therapeutics investors backed?

The most-backed portfolio companies among them are Cerevance (15), Ribometrix (15), Caraway Therapeutics (15), TopiVert (12) and Sitryx Therapeutics (12).

How do I contact Autifony Therapeutics investors?

Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.